ES2185384T3 - Pirrolo(2,1-b)(1,3)benzodiazepinas con actividad antipsicotica atipica. - Google Patents

Pirrolo(2,1-b)(1,3)benzodiazepinas con actividad antipsicotica atipica.

Info

Publication number
ES2185384T3
ES2185384T3 ES99936971T ES99936971T ES2185384T3 ES 2185384 T3 ES2185384 T3 ES 2185384T3 ES 99936971 T ES99936971 T ES 99936971T ES 99936971 T ES99936971 T ES 99936971T ES 2185384 T3 ES2185384 T3 ES 2185384T3
Authority
ES
Spain
Prior art keywords
atipica
antipsytic
benzodiazepins
pirrolo
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99936971T
Other languages
English (en)
Inventor
Giuseppe Campiani
Vito Nacci
Patrizia Minetti
Cesare Maria Assunta Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2185384T3 publication Critical patent/ES2185384T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compuestos, en forma racémica o como isómeros ópticos aislados, que tienen la fórmula (I): **(Fórmula)** en la que R = H, Cl, Br, F, I, alcoxi C1_4, alquiltio C1_4, alquilo C1_4 cicloalquilo C5_6; R1 = dialquilamina, 4-alquil-1-piperazinilo, 4-hidroxi-alquil-1-piperazinilo, 1-imidazolilo, 4-alquil-1piperidinilo, R2 = hidrógeno, alcoxi C1_4, alquiltio C1_4; y sus sales farmacéuticamente aceptables.
ES99936971T 1998-07-28 1999-07-27 Pirrolo(2,1-b)(1,3)benzodiazepinas con actividad antipsicotica atipica. Expired - Lifetime ES2185384T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001748A IT1301965B1 (it) 1998-07-28 1998-07-28 Pirrolo (2,1-b)(1,3) benzotiazepine con attivita' antipsicoticaatipica.

Publications (1)

Publication Number Publication Date
ES2185384T3 true ES2185384T3 (es) 2003-04-16

Family

ID=11380538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99936971T Expired - Lifetime ES2185384T3 (es) 1998-07-28 1999-07-27 Pirrolo(2,1-b)(1,3)benzodiazepinas con actividad antipsicotica atipica.

Country Status (13)

Country Link
US (1) US6391870B2 (es)
EP (1) EP1100803B1 (es)
JP (1) JP4523160B2 (es)
KR (1) KR100642730B1 (es)
AT (1) ATE225352T1 (es)
AU (1) AU762021B2 (es)
CA (1) CA2338651C (es)
DE (1) DE69903321T2 (es)
DK (1) DK1100803T3 (es)
ES (1) ES2185384T3 (es)
IT (1) IT1301965B1 (es)
PT (1) PT1100803E (es)
WO (1) WO2000006579A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317884B1 (it) 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Pirrolo (2,1-b)(1,3)benzotiazepine e loro uso per la preparazione dimedicamenti ad attivita' antipsicotica classica.
IT1317886B1 (it) * 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di 9,10-diidro-pirrolo (2,1-b)(1,3)benzotiazepine 9-ammino sostituite.
ITRM20040178A1 (it) * 2004-04-07 2004-07-07 Sigma Tau Ind Farmaceuti Composti ad attivita' antipsicotica atipica.
ITRM20040222A1 (it) 2004-05-07 2004-08-07 Sigma Tau Ind Farmaceuti Derivati dealchilati di pirrolo[2,1-b]benzotiazepine ad attivita' antipsicotica atipica.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines

Also Published As

Publication number Publication date
DE69903321D1 (de) 2002-11-07
KR20010072090A (ko) 2001-07-31
WO2000006579A3 (en) 2000-05-04
DK1100803T3 (da) 2002-12-30
WO2000006579A2 (en) 2000-02-10
ATE225352T1 (de) 2002-10-15
EP1100803A2 (en) 2001-05-23
PT1100803E (pt) 2003-02-28
ITMI981748A1 (it) 2000-01-28
CA2338651C (en) 2009-05-19
ITMI981748A0 (it) 1998-07-28
KR100642730B1 (ko) 2006-11-03
AU5193399A (en) 2000-02-21
JP2002521485A (ja) 2002-07-16
CA2338651A1 (en) 2000-02-10
EP1100803B1 (en) 2002-10-02
JP4523160B2 (ja) 2010-08-11
US6391870B2 (en) 2002-05-21
AU762021B2 (en) 2003-06-19
DE69903321T2 (de) 2003-06-18
IT1301965B1 (it) 2000-07-20
US20020006921A1 (en) 2002-01-17
HK1036793A1 (en) 2002-01-18

Similar Documents

Publication Publication Date Title
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
ID29076A (id) Kombinasi senyawa aktif fungisida
FR2778561B1 (fr) Azurants optiques comme agents blanchissants
TR199801629A2 (xx) Fungisidal 2 -metoksibenzofenonlar.
BR9804214A (pt) Compostos.
NO994877L (no) Kalsilytiske forbindelser
IT1283588B1 (it) Miscela sinergica di agenti stabilizzanti
GB9801690D0 (en) Therapeutic agents
NO20002173L (no) Pleuromutilin-derivater som antimikrobielle midler
AU2003285792A1 (en) The optical access network using wavelength-locked wdm optical source injected by incoherent light
ATE213491T1 (de) Fungizide 2-methoxybenzophenone
AR006390A1 (es) Derivados de lactama
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
NO982907D0 (no) Tyrosinderivater som <alfa>-v-integrininhibitorer
UY24006A1 (es) Derivado del 2-(2-amino -1,6-dihidro-6-oxo-purin-9-il)metoxil-1,3-propanodiol.
IT1269176B (it) Eterobicicli ad attivita' fungicida
DK1027348T3 (da) 2-(2'-hydroxyphenyl)benzotriazoler anvendt som UV-stabilisatorer
ES2189121T3 (es) Mezcla de estabilizantes para materiales organicos.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ES2185384T3 (es) Pirrolo(2,1-b)(1,3)benzodiazepinas con actividad antipsicotica atipica.
ES2125537T3 (es) Arilbenzoilguanidinas.
BR0010317A (pt) Bandeja de armazenagem para refrigerador
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
CO5580722A2 (es) Mezclas fungicidas
BR0110490A (pt) Agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina